International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ.
Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24.
Update on Lymphoblastic Leukemia/Lymphoma.
Luca DC.
Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003.
B Cell Lymphoma.
Meng X, Min Q, Wang JY.
Adv Exp Med Biol. 2020;1254:161-181. doi: 10.1007/978-981-15-3532-1_12.
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K, Sheikh T, Aggarwal N.
Semin Diagn Pathol. 2023 May;40(3):202-215. doi: 10.1053/j.semdp.2023.04.003. Epub 2023 Apr 9.
T-cell acute lymphoblastic leukemia.
Raetz EA, Teachey DT.
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):580-588. doi: 10.1182/asheducation-2016.1.580.
A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-10(6) and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients.
Tembhare PR, Subramanian Pg PG, Ghogale S, Chatterjee G, Patkar NV, Gupta A, Shukla R, Badrinath Y, Deshpande N, Narula G, Rodrigues P, Girase K, Dhaliwal D, Prasad M, Shetty D, Banavali S, Gujral S.
Cytometry B Clin Cytom. 2020 Jan;98(1):57-67. doi: 10.1002/cyto.b.21831. Epub 2019 Jun 14.
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity.
Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD Jr, Fuda FS, Chen W, Jaso JM.
Am J Clin Pathol. 2020 Nov 4;154(6):816-827. doi: 10.1093/ajcp/aqaa109.
Acute myelofibrosis superseding B-lymphoblastic leukemia/lymphoma.
El Hussein S, O'Dywer KM, Bennett JM.
EJHaem. 2023 Aug 8;4(4):1179-1181. doi: 10.1002/jha2.769. eCollection 2023 Nov.
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
Temple WC, Mueller S, Hermiston ML, Burkhardt B.
Best Pract Res Clin Haematol. 2023 Mar;36(1):101449. doi: 10.1016/j.beha.2023.101449. Epub 2023 Feb 16.
B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.
Zhang X, Rastogi P, Shah B, Zhang L.
Oncotarget. 2017 Jul 15;8(39):66728-66741. doi: 10.18632/oncotarget.19271. eCollection 2017 Sep 12.
